Dr. Shervin Tabrizi, MD
- Medicare services, 2023
- 45
- Medicare patients, 2024
- 11
- Part D claims, 2018
- 13
- Publications
- 24
- Hospital affiliations
- 1
- Practice address
- 3400 Spruce St, Philadelphia, PA 19104
- Practice phone
- Call (215) 662-6289
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Tabrizi's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Shervin Tabrizi is a radiation oncologist in Philadelphia, Pennsylvania
Dr. Tabrizi practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.
Dr. Tabrizi's NPI, 1104354109, was assigned on June 2, 2017. Dr. Tabrizi holds Massachusetts license 281654.
- NPI
- 1104354109NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2961773247
- NPI enumeration date
- June 2, 2017
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (215) 662-6289
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 35
- Medical school graduation
- 2017
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Shervin Tabrizi practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania
Dr. Tabrizi's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.
- Hospital of the University of Pennsylvania3400 Spruce St, Philadelphia, PA 19104 · Philadelphia CountyPhone(215) 662-6289
Source: Dmand AI Affiliation Data
Dr. Shervin Tabrizi is affiliated with 1 site of care and 3 medical groups
Dr. Tabrizi's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Tabrizi to 2 more medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Shervin Tabrizi's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tabrizi practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Hospital of the University of Pennsylvania | Available with a free account |
| +2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Pennsylvania and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Shervin Tabrizi is one of 304 radiation oncologists in Pennsylvania
Radiation oncology is Dr. Tabrizi's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Tabrizi is licensed in Massachusetts.
Specialties and state licenses
- Radiation oncology, MassachusettsPrimary
Radiation oncologists near Dr. Tabrizi
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Shervin Tabrizi billed Medicare for 45 services in 2023
CMS data shows 45 Medicare services from Dr. Tabrizi across 3 procedure codes in 2023, for 11 Medicare patients. Medicare paid $3,435 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Tabrizi compared with the Pennsylvania median for radiation oncologists, 2023
- Dr. Tabrizi
- Pennsylvania median
- Medicare services
- 45vs 1,02796% below
- Medicare patients
- 11vs 16093% below
- Part D claims
- 13vs 3967% below
Medians across 308 radiation oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Tabrizi's most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Tabrizi?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Tabrizi and other radiation oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Shervin Tabrizi treated 11 Medicare patients in 2024, average age 74
CMS counts 11 Medicare patients who saw Dr. Tabrizi in 2024. Their average risk score is 0.98, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Tabrizi's median patient age at 62, with 38% women.
Dr. Tabrizi's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 62
Patient panel by sex, all payers
- Women38%
- Men63%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Shervin Tabrizi wrote 13 Medicare Part D claims in 2018
In 2018, Dr. Tabrizi wrote 13 Medicare Part D claims. They cover 1 drug, with $322 in total drug cost.
Dr. Tabrizi's most prescribed drugs by claims, 2018
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
How Dr. Shervin Tabrizi takes part in Medicare
Dr. Tabrizi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Shervin Tabrizi has 24 publications on record
Dmand AI links 24 papers to Dr. Tabrizi, published from 2014 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Lassa Fever, Biomarkers, Tumor and Circulating Tumor DNA. Dr. Tabrizi has published most often in bioRxiv. Dr. Tabrizi's most frequent co-authors are John Scribner Schieffelin, MD, Helen Alice Shih, MD and Brian Michael Alexander, MD.
Dr. Tabrizi's papers by year, 2014 to 2025
Topics Dr. Tabrizi writes about most
- Lassa Fever
- Biomarkers, Tumor
- Circulating Tumor DNA
- Lassa virus
- Algorithms
- Cell-Free Nucleic Acids
- Clinical Competence
- Genome, Human
Dr. Tabrizi's most frequent co-authors
- John Scribner Schieffelin, MD3 shared papers
- Helen Alice Shih, MD3 shared papers
- Brian Michael Alexander, MD2 shared papers
Recent publications by Dr. Tabrizi
Trends Cell Biol
Single duplex DNA sequencing with CODEC detects mutations with high sensitivity (opens in a new tab)
Nat Genet
See who Dr. Tabrizi researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Tabrizi works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Shervin Tabrizi received $194 in industry payments in 2025
CMS Open Payments shows 1 general payment to Dr. Tabrizi from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. MicroVention, Inc. paid the most, $194.
Companies that paid Dr. Tabrizi the most, 2025 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Shervin Tabrizi's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Shervin Tabrizi
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Shervin Tabrizi's NPI number?
Dr. Shervin Tabrizi's NPI number is 1104354109. It was assigned on June 2, 2017, and it is active in the NPI Registry.
What kind of doctor is Dr. Shervin Tabrizi?
Dr. Shervin Tabrizi is a radiation oncologist in Philadelphia, Pennsylvania. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Shervin Tabrizi practice?
Dr. Tabrizi practices at 3400 Spruce St, Philadelphia, PA 19104. Dr. Tabrizi's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dmand AI also links Dr. Tabrizi to 2 medical groups.
What is Dr. Shervin Tabrizi's office phone number?
The practice phone on file for Dr. Tabrizi is (215) 662-6289.
What is Dr. Shervin Tabrizi's medical license number?
Dr. Tabrizi holds Massachusetts license 281654.
Which hospitals is Dr. Shervin Tabrizi affiliated with?
Dr. Tabrizi practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania.
What medical group is Dr. Shervin Tabrizi part of?
Dr. Tabrizi is linked to Massachusetts General Physicians Organization (MGPO). Dmand AI links Dr. Tabrizi to 2 more medical groups.
Does Dr. Shervin Tabrizi accept Medicare?
Yes. CMS data shows Dr. Tabrizi billed Medicare for 45 services in 2023, and Dr. Tabrizi accepts Medicare assignment.
How many Medicare patients does Dr. Shervin Tabrizi see?
CMS counts 11 Medicare patients who saw Dr. Tabrizi in 2024, with an average age of 74.
What services does Dr. Shervin Tabrizi bill to Medicare?
In 2023, Dr. Tabrizi's most billed Medicare services were radiation oncology (77334), radiation oncology (77427) and radiation oncology (77280).
Show 5 more questionsShow fewer questions
What drugs does Dr. Shervin Tabrizi prescribe most?
In 2018 Medicare Part D data, Dr. Tabrizi's most prescribed drugs by claims were Ceftriaxone.
Has Dr. Shervin Tabrizi received payments from drug or device companies?
CMS Open Payments shows $194 in general payments to Dr. Tabrizi from 1 company from 2025 to 2025. The largest total came from MicroVention, Inc.
How long has Dr. Shervin Tabrizi been practicing?
Dr. Tabrizi graduated from medical school in 2017, 9 years ago.
Does Dr. Shervin Tabrizi do research?
Dmand AI links 24 publications to Dr. Tabrizi, published from 2014 to 2025.
Who does Dr. Shervin Tabrizi publish with?
Dr. Tabrizi's most frequent co-authors are John Scribner Schieffelin, MD (3 shared papers), Helen Alice Shih, MD (3 shared papers) and Brian Michael Alexander, MD (2 shared papers).
Selling to radiation oncology practices?
See radiation oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card